Understanding the Future of the Pharma Contract Manufacturing Market: Pharma IQ 2025 Market Report

The pharmaceutical industry is undergoing a rapid transformation, with Contract Manufacturing Organisations (CMOs) and Contract Development and Manufacturing Organisations (CDMOs) playing an increasingly vital role. Ahead of the Pharma Contract Manufacturing Summit 2025, Pharma IQ has put together a comprehensive market report, that delves into the trends, challenges, and opportunities shaping the future of pharmaceutical manufacturing.

Why Download This Report? This resource provides actionable insights for industry professionals navigating the complexities of pharmaceutical manufacturing. From building resilient supply chains to achieving sustainability goals, the report serves as a roadmap for optimising partnerships, operations, and compliance.

Download the report now to explore how you can stay ahead in a rapidly evolving market. Key takeaways include: 

• Market Insights: Learn how the global CMO/CDMO market is projected to reach $310.9 billion by 2030, driven by demand for outsourcing and innovative drugs.
• Digital Transformation: Discover how AI, IoT, and smart manufacturing are revolutionising operational efficiency and regulatory compliance.
• Sustainability: Explore how green chemistry, carbon neutrality, and sustainable packaging are redefining industry standards.
• Geopolitical Complexities: Understand how regulations like the BIOSECURE Act and regional strategies are reshaping supply chain resilience.
• Innovation: Learn about the role of additive manufacturing, predictive analytics, and lights-out manufacturing in driving future growth.